Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF- κB and MAPK Signaling Pathways

ConclusionOur results showed that bicyclol has potential as a drug to treat obesity-induced cardiomyopathy.

Source: Cardiovascular Drugs and Therapy - June 24, 2022 Category: Cardiology Source Type: research